BioIntel
Pomelo Care Secures $92M to Expand Beyond Maternity Healthcare
Healthcare Investment

Pomelo Care Secures $92M to Expand Beyond Maternity Healthcare

BioIntel Editorial TeamBioIntel Editorial TeamJan 10, 20264 min

With participation from prominent investors including Andreessen Horowitz and Atomico, Pomelo plans to leverage the funding to expand its care models and technologies beyond maternity services, potentially impacting women’s health more broadly.

Financing Details

  • Raised $92 million in Series C funding.
  • Led by Stripes with Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup, SV Angel participation.

Strategic Growth

  • Expansion plans beyond initial focus on maternity care.
  • Potential to address wider women’s health and family care needs.

Industry Significance

  • Reflects investor confidence in digital and personalized healthcare models.
  • Aligns with broader trends to support maternal and women’s health innovations.

Source: Pomelo Care Series C - MedCity News

Join the BioIntel newsletter

Get curated biotech intelligence across AI, industry, innovation, investment, medtech, and policy—delivered to your inbox.